EPSILON-MALEIMIDOCAPROIC ACIDHazard Codes : XiRisk Statements : 36/37/38Safety Statements : 26-36WGK Germany : 3F : 10-21

EPSILON-MALEIMIDOCAPROIC ACIDHazard Codes : XiRisk Statements : 36/37/38Safety Statements : 26-36WGK Germany : 3F : 10-21

BioQuadrant Inc is a chemistry-based service provider to the biotech and pharmaceutical industry, specializing in drug discovery, contract research and preclinical small-scale production of API up to kilogram-level. The company is based in Laval, Quebec, Canada, one of North America's fastest growing and most successful biotechnology hubs. BioQuadrant's unique approach focuses on preclinical chemical process development and production of active ingredients for pre-clinical trials, thereby allowing its clients to make the critical transition from lab bench to pre-clinical trials in the shortest time and at a competitive cost.The company was founded in 1999, and has successfully completed numerous projects in the field of HIV protease inhibitors, cardiovascular drugs (thrombin inhibitors), ophthomology, analgesics and sedatives, anticonvulsants, anti-diabetes and anti-obesity drugs. Our proven track record in the field of pre-clinical chemistry and our unique in-house developed expertise in the creation of new building blocks and pharmaceutical intermediates, make BioQuadrant a perfect partner for early-stage and emerging companies.